Cas 130571-38-9,1-{4-[4-(2,4-Diamino-6-methyl-5-pyrimidinyl)-1-piperazinyl]-phenyl}-4-(diethyl-amino)-1-butanone

130571-38-9

Post Buying Request

Basic information

Product Name: 1-{4-[4-(2,4-Diamino-6-methyl-5-pyrimidinyl)-1-piperazinyl]-phenyl}-4-(diethyl-amino)-1-butanone
Synonyms: 1-{4-[4-(2,4-Diamino-6-methyl-5-pyrimidinyl)-1-piperazinyl]-phenyl}-4-(diethyl-amino)-1-butanone
CAS NO:130571-38-9
Molecular Formula:
Molecular Weight: 425.577
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-{4-[4-(2,4-Diamino-6-methyl-5-pyrimidinyl)-1-piperazinyl]-phenyl}-4-(diethyl-amino)-1-butanone(CAS DataBase Reference)
NIST Chemistry Reference: 1-{4-[4-(2,4-Diamino-6-methyl-5-pyrimidinyl)-1-piperazinyl]-phenyl}-4-(diethyl-amino)-1-butanone(130571-38-9)
EPA Substance Registry System: 1-{4-[4-(2,4-Diamino-6-methyl-5-pyrimidinyl)-1-piperazinyl]-phenyl}-4-(diethyl-amino)-1-butanone(130571-38-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 130571-38-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

130571-38-9 Suppliers

Recommended suppliers

130571-38-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 130571-38-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,5,7 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 130571-38:
(8*1)+(7*3)+(6*0)+(5*5)+(4*7)+(3*1)+(2*3)+(1*8)=99
99 % 10 = 9
So 130571-38-9 is a valid CAS Registry Number.

130571-38-9Upstream product

348-04-9 4-diethylamino-1-(4-fluoro-phenyl)-butan-1-one

130571-38-9Downstream Products

130571-38-9Relevant academic research and scientific papers

Diaminopyrimidines and combination therapies effective for treatment of P-glycoprotein positive cancers

-

Page/Page column 13-14, (2010/02/05)

The present invention provides compounds of Formula II:

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 130571-38-9